Insulin-like growth factors sustain insulin-like growth factor-binding protein-5 expression in osteoblasts

被引:17
|
作者
Gabbitas, B
Canalis, E
机构
[1] St Francis Hosp & Med Ctr, Dept Res, Hartford, CT 06105 USA
[2] St Francis Hosp & Med Ctr, Dept Med, Hartford, CT 06105 USA
[3] Univ Connecticut, Sch Med, Farmington, CT 06030 USA
关键词
skeletal tissue; extracellular matrix; bone formation; transcription;
D O I
10.1152/ajpendo.1998.275.2.E222
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin-like growth factors (IGFs)I and II are considered to be autocrine regulators of bone cell function. Recently, we demonstrated that IGF-I induces IGF-binding protein-5 (IGFBP-5) expression in cultures of osteoblast-enriched cells from 22-day fetal rat calvariae (Ob cells). In the present study, we postulated that IC;Fs play an autocrine role in the maintenance of IGFBP-5 basal expression in Ob cells. IGFBP-2 and -3, at concentrations that bind endogenous IGFs, decreased IGFBP-5 mRNA levels, as determined by Northern blot analysis, and protein levels, as determined by Western immunoblots of extracellular matrix extracts of Ob cells. IGFBP-8 and -3 in excess inhibited IGFBP-5 heterogeneous nuclear RNA levels, as determined by RT-PCR, and did not alter the half-life of IGFBP-5 mRNA in transcriptionally arrested Ob cells. In conclusion, blocking endogenous IGFs in Ob cells represses IGFBP-5 expression, suggesting that IGFs are autocrine inducers of IGFBP-5 synthesis in osteoblasts.
引用
收藏
页码:E222 / E228
页数:7
相关论文
共 50 条
  • [31] The insulin-like growth factor-binding protein (IGFBP) superfamily
    Hwa, V
    Oh, Y
    Rosenfeld, RG
    [J]. ENDOCRINE REVIEWS, 1999, 20 (06) : 761 - 787
  • [32] Risk of prevalent and incident dementia associated with insulin-like growth factor and insulin-like growth factor-binding protein 3
    Almeida, O. P.
    Hankey, G. J.
    Yeap, B. B.
    Chubb, S. A. Paul
    Gollege, J.
    Flicker, L.
    [J]. MOLECULAR PSYCHIATRY, 2018, 23 (08) : 1825 - 1829
  • [33] Risk of prevalent and incident dementia associated with insulin-like growth factor and insulin-like growth factor-binding protein 3
    O P Almeida
    G J Hankey
    B B Yeap
    S A Paul Chubb
    J Gollege
    L Flicker
    [J]. Molecular Psychiatry, 2018, 23 : 1825 - 1829
  • [34] Insulin-like growth factor-I and insulin-like growth factor-binding proteins in the nephrotic syndrome
    Feld, SM
    Hirschberg, R
    [J]. PEDIATRIC NEPHROLOGY, 1996, 10 (03) : 355 - 358
  • [35] Nomenclature of the insulin-like growth factor-binding protein superfamily
    Rosenfeld, RG
    Hwa, V
    Oh, Y
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02): : 946 - 946
  • [36] Comparative endocrinology of the insulin-like growth factor-binding protein
    Kelley, KM
    Schmidt, KE
    Berg, L
    Sak, K
    Galima, MM
    Gillespie, C
    Balogh, L
    Hawayek, A
    Reyes, JA
    Jamison, M
    [J]. JOURNAL OF ENDOCRINOLOGY, 2002, 175 (01) : 3 - 18
  • [37] INSULIN-LIKE GROWTH FACTOR-I AND INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN IN THE TOAD, BUFO-WOODHOUSEI
    PANCAKROESSLER, MK
    LEE, PDK
    [J]. GENERAL AND COMPARATIVE ENDOCRINOLOGY, 1990, 78 (02) : 263 - 272
  • [38] Expression of insulin-like growth factor-binding protein 2 in melanocytic lesions
    Wang, HM
    Shen, SS
    Wang, H
    Diwan, AH
    Zhang, W
    Fuller, GN
    Prieto, VG
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 2003, 30 (10) : 599 - 605
  • [39] Osteoblast-specific expression of insulin-like growth factor-1 in bone of transgenic mice induces insulin-like growth factor binding protein-5
    Rutter, MM
    Markoff, E
    Clayton, L
    Akeno, N
    Zhao, GS
    Clemens, TL
    Chernausek, SD
    [J]. BONE, 2005, 36 (02) : 224 - 231
  • [40] In vivo evidence for estradiol-controlled insulin-like growth factor-I and insulin-like growth factor binding protein-5 expression in bone cells
    Colin, EM
    Lindenbergh-Kortleve, DJ
    van den Bemd, GJCM
    Buurman, CJ
    van Neck, JW
    Drop, SLS
    Pols, HAP
    van Leeuwen, JPTM
    [J]. BONE, 2001, 28 (05) : S91 - S91